144690-92-6

• 常用中文名：三苯甲基奥美沙坦酯
• 常用英文名：Trityl Olmesartan Medoxomil
• CAS号：144690-92-6
• 分子式：C₄₈H₄₆N₆O₆
• 分子量：802.915
• 发布时间：2018-07-20 09:34:57
• 更新时间：2026-07-07 13:34:55

名称

• 中文名: 三苯甲基奥美沙坦酯
• 英文名: Trityl Olmesartan Medoxomil
• 中文别名: 三苯甲基奥美沙坦酯(奥美沙坦酯中间体); (5-甲基-2-氧-1,3-二氧基-4-基)甲基4-(1-羟基-1-甲基乙基)-2-丙基-1-{4-[2-(TRITYLTETRAZOL-5-YL)PHENYL]PHENYL}甲基咪达德-5-羧酸酯; N1奥美沙坦三甲基酯; ( 4-(2-羟异丙基)-2-丙基-1-((2'-(2-三苯甲基-2H-四唑-5-基)-4-甲基-1H-咪唑-5-甲酸(5-甲基-2-氧杂-1,3-二氧-4-甲基)酯; 三苯甲基奥美沙坦; 三苯甲基奥美沙坦酯(奥美沙坦甲氧菊酯中间体); 奥美沙坦酯杂质; 奥美沙坦酯杂质D; 化合物：Tritylolmestan Medoxomil; 三苯基奥美沙坦酯 (OM2); 奥美沙坦三角; N1三苯甲基奥美沙坦酯; 奥美沙坦酯杂质16; 奥美沙坦酯D; 化合物:Tritylolmestan Medoxomil; 奥美沙坦酯N1-TRITYL杂质; 奥美沙坦杂质D; 4(1-羟基-1-甲基乙基)-2-丙基-1-[[2'-[1-(三苯基甲基)-1H-四唑-5-基][1,1'-联苯]-4-基]甲基]-1H-咪唑-5-羧酸 (5-甲基-2-氧代-1,3-二氧杂-4-基)甲酯; 奥美沙坦酯杂质 D; 美沙坦酯杂质D; (5-甲基-2-氧代-1,3-二氧戊环-4-基)甲基 4-(2-羟基丙-2-基)-2-丙基-1-((2'-(1-三苯基-1H-四唑-5-基)-[1,1'-联苯]-4-基)甲基)-1H-咪唑-5-羧酸酯; 三苯甲基奥美沙坦酯 中间体; 三苯甲基奥美沙坦(奥美沙坦酯杂质)
• 英文别名: 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-cboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; N1-Trityl Olmestan Medoxomil 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-[1- (triphenylmethyl)-1H-tetrazol-5-yl][1,1’-biphenyl]-4-yl]methyl]- 1H-Imidazole-5-cboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4- yl)Methyl Ester; Trityl Olmestan Medoxomil (Intermediate of Olmestan medoxomil); Trityl olmestan medoxomil (Olmestan Medoxomi Impurity); 1H-Imidazole-5-cboxylic acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; N1-Trityl OlMestan MedoxoMil; (5-Methyl-2-oxo-1,3-dioxolan-4-yl)methyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylate; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxolan-4-yl)methyl ester; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-cboxylate; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cboxylate; Olmestan ester impurity D; Trityl olmestan medoxomil, >=; OlMestan trityl; InterMediate of OlMestan MedoxoMil; 1H-Imidazole-5-cboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; Olmestan Medoxomil-4; OMSTint-G; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-cboxylate; Triphenyl methyl olmesartan; Tritylolmestan medoxomil (OR) (5-methyl-2-oxo-1,3-dioxol-4- yl)methyl 5-(2-hydroxypropan-2-yl)- 2-propyl-3-[[4-[2-(1-trityltetrazol-5- yl)phenyl]phenyl]methyl]imidazole-4- cboxylate; Olmestan Medoxomil impurity 13/ N1-Trityl Olmestan Medoxomil/(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cboxylate; Atila; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate; (5-methyl-2-oxo-1,3-dioxolen-4-yl) methyl-4-1 (1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-trityltetrazol-5-yl)phenyl] phenyl} methylimidazole-5-cboxylate; OlMestan MedoxoMil N1-Trityl IMpurity; N-Triphenyl Methyl Omestan; 3-((3'-cbamoyl-[1,1'-biphenyl]-3-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-cboxylic acid; (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidde-5-cboxylate; OlMestan IMp D (Trityl OlMestanMedoxoMil); Olmestan Medoxomil Impurity16; Trithyl Olmestan; TIANFU-CHEM - Trityl olmestan; Folusen; Trityl olmestan; Olmestan medoxomil D; TRITYL OLMESTAN MEDOXOMIL; Azilstan medoxomil impurity238; Triphenylolmestanester(OM2); Olmestan1 Impurity 31; (5-methyl-2-oxo-1,3-dioxol-4-yl) 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]- 1H-Imidazole-5-cboxylic acid (Trityl Olmestan); (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-cboxylate; Trityl olmestan ISO 9001：2015 REACH; Tritylolmestan(ForOlmestan); 5-Methoxy-2-oxo-1,3-dioxol-4-yl)methyl-4-(1-hydroxy-1-methylethyl); Olmestan MedoxomiI Impurity D; TRIPHENYL METHYL OLMESTAN; Olmestan Impurity D; 5-Methoxy – 2-oxo-1,3-dioxol - 4 - yl ) methyl - 4 - (1-hydroxy -1 - methylethyl -2 propyl-1- (2 –(2-triphenylmethyl ) -2H – tetrazole -5 – yl ) biphenyl -4-yl ) methyl ) -1H-imidazole – 5 – cboxylate

物化性质

• 密度: 1.3±0.1 g/cm3
• 沸点: 988.3±75.0 °C at 760 mmHg
• 熔点: 104-106°C
• 分子式: C₄₈H₄₆N₆O₆
• 分子量: 802.915
• 闪点: 551.5±37.1 °C
• 精确质量: 802.347900
• PSA: 143.48000
• LogP: 8.73
• 蒸汽压: 0.0±0.3 mmHg at 25°C
• 折射率: 1.648
• 储存条件: Refrigerator

安全

• 危害码 (欧洲): Xi
• 海关编码: 2933990090

合成路线

上下游产品

上游产品  8
80841-78-7 761404-85-7 80715-22-6 144690-33-5
144978-05-2 124750-51-2 879097-59-3 144689-93-0
下游产品  2
76-84-6 144689-63-4

海关

海关编码	2933990090
中文概述	2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%